Following DNA sequencing studies further validated that mutations in the WNT–β-catenin pathway genes are the main genetic events in hepatoblastoma and also identified other rare genetic mutations in NFE2L2 and TERT genes [16–25]. The gene discussed is NFE2L2; the disease is hepatoblastoma.